3071 - 3080 of 8654 Results
Title
Year
- Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging2022OPENTitle: Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR ImagingJournal Name: American Journal of NeuroradiologyPublisher: American Society of Neuroradiology (ASNR)Vol: 43Issue #: 3Start Page: 354End Page: 360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3174/ajnr.a7410Best OA location URL: https://www.ajnr.org/content/ajnr/43/3/354.full.pdfCitation Count: 3
-
OPENTitle: RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursorsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202307092Best OA location URL: https://rupress.org/jcb/article-pdf/223/6/e202307092/1926155/jcb_202307092.pdfCitation Count: 10
-
OPENTitle: Perceived Discrimination in Health Care for LGBTQIA+ People Living With Parkinson’s DiseaseJournal Name: The Journals of Gerontology: Series BPublisher: Oxford University Press (OUP)Vol: 78Issue #: 9Start Page: 1459End Page: 1465Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/geronb/gbad046Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10461524Citation Count: 9
- Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body Disease2025RESTRICTEDTitle: Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.30238Citation Count: 0
- A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein2018OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 52
- A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s disease2019OPENTitle: A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 514Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aau6870Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7359409Citation Count: 94
- NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p622023OPENTitle: NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62Journal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-44033-0Best OA location URL: https://escholarship.org/uc/item/14x6349kCitation Count: 25
- Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy2023OPENTitle: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106287End Page: 106287Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106287Citation Count: 9
- Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank2018OPENTitle: Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think TankJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00734Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00734/pdfCitation Count: 70
- Quantifying arm swing in Parkinson’s disease: a method accounting for arm activities during free-living gait2025OPENTitle: Quantifying arm swing in Parkinson’s disease: a method accounting for arm activities during free-living gaitJournal Name: Journal of NeuroEngineering and RehabilitationPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12984-025-01578-zBest OA location URL: https://doi.org/10.1186/s12984-025-01578-zCitation Count: 0